Report: FDA fails to monitor clinical researchers' financial conflicts

The FDA failed to implement rules that require drug and device firms to detail the financial interests of outside experts who test experimental treatments before companies file for approval, according to a report from the HHS' inspector general. The study is based on 118 new-drug applications that the FDA cleared in 2007. An FDA spokeswoman said the agency does not favor examining clinical investigators' financial conflicts prior to trials because they represent only one source of bias.

View Full Article in:

Los Angeles Times (tiered subscription model) · NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY